Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia

…, N Lomakin, BM Goloshchekin, E Nahorecka… - medRxiv, 2022 - medrxiv.org
Rationale There are few treatment options for severe COVID-19 pneumonia. Opaganib is an
oral treatment under investigation. Objective Evaluate opaganib treatment in hospitalized …

[CITATION][C] Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia (preprint)

…, N Lomakin, BM Goloshchekin, E Nahorecka… - 2022